A detailed history of Thrivent Financial For Lutherans transactions in Care Dx, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 57,939 shares of CDNA stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,939
Previous 81,331 28.76%
Holding current value
$1.28 Million
Previous $2.54 Million 51.16%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$20.4 - $32.2 $477,196 - $753,222
-23,392 Reduced 28.76%
57,939 $1.24 Million
Q2 2024

Aug 13, 2024

SELL
$7.56 - $16.15 $26,255 - $56,088
-3,473 Reduced 4.1%
81,331 $1.26 Million
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $415,539 - $1.09 Million
84,804 New
84,804 $1.02 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.18B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.